Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
51 results:

  • 1. Transcriptome profiling of human col\onic cells exposed to the gut pathobiont Streptococcus gallolyticus subsp. gallolyticus.
    Pasquereau-Kotula E; du Merle L; Sismeiro O; Pietrosemoli N; Varet H; Legendre R; Trieu-Cuot P; Dramsi S
    PLoS One; 2023; 18(11):e0294868. PubMed ID: 38033043
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.
    Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
    Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective pim1 inhibitor in human colon cancer.
    Park YS; Kim J; Ryu YS; Moon JH; Shin YJ; Kim JH; Hong SW; Jung SA; Lee S; Kim SM; Lee DH; Kim DY; Yun H; You JE; Yoon DI; Kim CH; Koh DI; Jin DH
    Cancer Biol Ther; 2023 Dec; 24(1):2246208. PubMed ID: 37621144
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
    Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
    Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patterns of emergency department visits before diagnosis with digestive neuroendocrine neoplasms.
    Abdel-Rahman O; Ghosh S
    Int J Colorectal Dis; 2023 May; 38(1):148. PubMed ID: 37253995
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dissecting the heterogeneities of the tumor microenvironment between metastatic and nonmetastatic primary colorectal cancer patients by single-cell RNA sequencing.
    Wang S; Deng S; Jin X; Chen W; Wang X; Zhan H; Fang X; Fu J
    Life Sci; 2023 May; 320():121576. PubMed ID: 36933827
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. What are the problems with the current staging of discontinuous tumour nodules (DTNs) in colorectal carcinoma? Is there a better way?
    Karbanowicz E; Fuchs TL; Chou A; Sioson L; Sheen A; Ahadi MS; Gill AJ
    Pathology; 2022 Dec; 54(7):848-854. PubMed ID: 36241558
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Collaborative multi-feature extraction and scale-aware semantic information mining for medical image segmentation.
    Zhang R; He Z; Zhu J; Yuan X; Huang G; Pun CM; Peng J; Lin J; Zhou J
    Phys Med Biol; 2022 Oct; 67(20):. PubMed ID: 36170875
    [No Abstract]    [Full Text] [Related]  

  • 9. Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer.
    Niloofa R; De Zoysa MI; Seneviratne LS
    J Cancer Res Ther; 2021; 17(4):819-833. PubMed ID: 34528528
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and pim-1 kinase enzymes.
    El-Miligy MMM; Al-Kubeisi AK; El-Zemity SR; Nassra RA; Abu-Serie MM; Hazzaa AA
    Bioorg Chem; 2021 Oct; 115():105171. PubMed ID: 34303896
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.
    Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
    Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic and immunomodulatory effects of pim1 in colorectal carcinoma.
    Zhou Y; Zhou Y; Liu S; Wang J; Ji R; Yan X
    J BUON; 2021; 26(2):513-520. PubMed ID: 34077000
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of pim3 in prognosis of colon cancer.
    Zhou Y; Zhou YN; Liu SX; Wang J; Ji R; Yan X
    Clin Transl Oncol; 2021 Oct; 23(10):2163-2170. PubMed ID: 33928496
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-term anorectal function in rectal cancer patients treated with chemoradiotherapy and endorectal brachytherapy.
    Faaborg PM; Haas S; Liao D; Ploen J; Jakobsen A; Rahr HB; Laurberg S; Gregersen H; Lundby L; Christensen P; Krogh K
    Colorectal Dis; 2021 Sep; 23(9):2311-2319. PubMed ID: 33900676
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New Quinoxaline Derivatives as Dual pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
    Oyallon B; Brachet-Botineau M; Logé C; Robert T; Bach S; Ibrahim S; Raoul W; Croix C; Berthelot P; Guillon J; Pinaud N; Gouilleux F; Viaud-Massuard MC; Denevault-Sabourin C
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562106
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PAI1 is a Marker of Bad Prognosis in Rectal cancer but Predicts a Better Response to Treatment with pim Inhibitor AZD1208.
    Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TAB3 upregulates pim1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevalence and factors associated with potentially inappropriate medication use in older medicare beneficiaries with cancer.
    Feng X; Higa GM; Safarudin F; Sambamoorthi U; Chang J
    Res Social Adm Pharm; 2020 Oct; 16(10):1459-1471. PubMed ID: 31926877
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Label-Free Nanoplasmonic Biosensing of cancer Biomarkers for Clinical Diagnosis.
    Portela A; Peláez EC; Calvo-Lozano O; Estévez MC; Lechuga LM
    Methods Mol Biol; 2019; 2027():115-140. PubMed ID: 31309477
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.